New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Recent launches and approvals include the HeartWare ventricular assist system, Roche’s Elecsys HE4 assay for ovarian cancer and Coloplast’s Altis single-incision sling system.
You may also be interested in...
FDA Sticks Newly Approved HeartWare VAD With Unexpected Labeling Requirement
HeartWare International Inc.’s HeartWare Ventricular Assist System has finally gained PMA approval, but FDA labeling requirements have sparked questions from analysts.
FDA Panel Supports HeartWare VAD, Despite Trial Shortcomings
Benefits of HeartWare system, as well as the prospect of adding a competitive device to a market currently dominated by a single product, overshadow uncertainties from missing data, panelists vote.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.